Expertise in
2
conditions

Hongxin Piao

Yanbian Korean Autonomous Prefecture, P.R. China, 
Longjing, CN 
Expertise in
2
conditions
Yanbian Korean Autonomous Prefecture, P.R. China, 
Longjing, CN 

Overview

Hongxin Piao practices practicing medicine in Longjing, China.

Piao is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Cirrhosis, Hepatitis B, Hepatitis, and Liver Cancer.

They are actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 4 clinical trials.

Locations

Yanbian Korean Autonomous Prefecture, P.R. China, Longjing, 133099, China
Other Locations
Jilin, 133000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Enrollment Status: Unknown
Publish Date: April 28, 2021
Intervention Type: Drug
Study Drug: Entecavir
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

22 Total Publications

FUBP3 regulates expression and alternative splicing of genes associated with cell proliferation and apoptosis in cancer cells.
FUBP3 regulates expression and alternative splicing of genes associated with cell proliferation and apoptosis in cancer cells.
Journal: Oncology letters
Published: November 26, 2025

Frequently Asked Questions about Hongxin Piao

Is Hongxin Piao a top-rated expert for Cirrhosis?

MediFind is an objective health platform that identifies experts based on real-world data. Hongxin Piao is classified as an Advanced expert for Cirrhosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hongxin Piao participate in research or clinical trials?

Yes. Hongxin Piao has published 22 articles and abstracts on conditions like Cirrhosis. You can view a list of Hongxin Piao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Piao's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile